Société Générale launches the first 100% certificate based on the Next Biotech

Sebastian David from Société Générale opens the Trading Day in Paris.

Société Générale innovates with the launch of the first 100% Certificate indexed on Next Biotech in partnership with Euronext . The Next Biotech index  is calculated and issued by Euronext. It is composed of values from the European Biotech sector listed on Euronext and Alternext , weighted in accordance with their market capitalization. The index allows investors, fund managers and issuers to follow the performance on a European scale of biotechnologies and innovative sectors with huge growth potential. The 100% Certificate Next Biotech , issued by Société Générale allows the beneficiary , in one single transaction and at a minimum charge ( 1% annual commission), to get the market performance of the diversified basket of biotechnology shares. It is continously listed on Euronext Paris from 09h05 to 17h30 and is traded as a simple share with the help of an online broker or their bank.